Internal Medicine, Hematology · Houston, TX
NPI
1982876272
Since 2008
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$74K
755 services
Medicare patients, 2024
166
Average age 72
Drug cost, 2024
$2.0M
304 prescriptions
Company payments, 2025
$724
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yesid Alvarado Valero was code 99215 (office e&m - established), 303 times for 107 patients. In total Yesid Alvarado Valero billed 755 services in 10 codes, and Medicare paid $74K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-07-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 303 | 107 | $105.67 | $32K |
| 99233 Hospital E&M - Subsequent | Facility | 301 | 49 | $94.55 | $28K |
| 99214 Office E&M - Established | Facility | 81 | 41 | $76.93 | $6,231 |
| 99205 Office E&M - New | Facility | 22 | 22 | $140.13 | $3,083 |
| 99223 Hospital E&M - Initial | Facility | 20 | 18 | $135.80 | $2,716 |
| 99441 Telephone Services | Office | 11 | 11 | $42.32 | $466 |
By year: 2022 $82K for 831 services; 2023 $117K for 1,134 services; 2024 $74K for 755 services.
Medicare prescription drug claims, 2024
In 2024, the drug Yesid Alvarado Valero prescribed most often to Medicare patients was Venclexta (Venetoclax), with 73 prescriptions and refills. In total Yesid Alvarado Valero wrote 304 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Venclexta Venetoclax | 73 | 73 | 14 | $176K |
| Valacyclovir Valacyclovir Hcl | 32 | 34 | 17 | $744 |
| Idhifa Enasidenib Mesylate | 25 | 25 | Under 11 | $863K |
| Levofloxacin Generic | 18 | 19 | 16 | $150 |
| Rosuvastatin Calcium Generic | 13 | 13 | Under 11 | $55.66 |
| Posaconazole Generic | 11 | 11 | Under 11 | $8,387 |
| Voriconazole Generic | 11 | 11 | Under 11 | $9,462 |
Brand drugs: 144 claims; generic drugs: 160 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yesid Alvarado Valero $724 ($724 in general payments such as food, travel and fees) from 10 companies. The largest payer was Astellas Pharma US Inc with $311.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc 4503.T | 4 | $311 |
| Syndax Pharmaceuticals, Inc. SNDX | 1 | $124 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $91.22 |
| BeOne Medicines USA, Inc. ONC | 1 | $34.22 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $33.04 |
| Rigel Pharmaceuticals, Inc. RIGL | 1 | $31.6 |
| Lilly USA, LLC LLY | 1 | $29.05 |
| Geron Corporation GERN | 1 | $27.48 |
| Abbvie Inc. ABBV | 1 | $22.88 |
| GlaxoSmithKline, LLC. GSK | 1 | $18.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.